Induced Interleukin-19 Contributes to Cell-Mediated Immunosuppression in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass

Interleukin-19 reduces T-cell responses and promotes the regulatory activity of CD4+ T cells. Induced IL-19 in patients undergoing CABG with CPB contributes to cell-mediated immunosuppression.